Decrease in growth factor receptors after treatment with serine protease inhibitor ONO-3403.

International journal of oncology

Volumn 20, Issue 4, 2002, Pages 797-802

  Hiwasa, Takaki ^a   Shimada, Hideaki ^a   Ochiai, Takenori ^a   Liu, Tian Ling ^a   Yuasa, Yasuhito ^a   Takiguchi, Masaki ^a   Ohkoshi, Motohiro ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLGLYCINE; BENZAMIDINE DERIVATIVE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; ETHYL N ALLYL N (2 METHYL 3 (4 (4 AMIDINOPHENOXYCARBONYL)PHENYL)PROPENOYL)AMINOACETATE METHANESULFONATE; ETHYL N-ALLYL-N-(2-METHYL-3-(4-(4-AMIDINOPHENOXYCARBONYL)PHENYL)PROPENOYL)AMINOACETATE METHANESULFONATE; FORMAZAN; MTT FORMAZAN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SERINE PROTEINASE INHIBITOR; TETRAZOLIUM; TYROSINE;

ANIMAL; ARTICLE; CELL CYCLE; CELL STRAIN 3T3; CELL SURVIVAL; DRUG EFFECT; FLOW CYTOMETRY; METABOLISM; MOUSE; PHOSPHORYLATION; SERODIAGNOSIS; WESTERN BLOTTING;

3T3 CELLS; ALLYLGLYCINE; ANIMALS; BENZAMIDINES; BLOTTING, WESTERN; CELL CYCLE; CELL SURVIVAL; FLOW CYTOMETRY; FORMAZANS; MICE; PHOSPHORYLATION; PRECIPITIN TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SERINE PROTEINASE INHIBITORS; TETRAZOLIUM SALTS; TYROSINE;

MLCS; MLOWN;

EID: 0036548742     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.20.4.797     Document Type: Article

References (0)